Guillemant S, Kremer R
Ann Biol Clin (Paris). 1978;36(6):491-6.
A radiocompetitive estimation of 25-hydroxyvitamin D in human serum is described. After extraction, a stage of purification by chromatography on a Sephadex LH 20 column permits separation of 25-hydroxyvitamin D from Vitamin D and other metabolites. The reaction of radiocompetition uses as tracer tritiated 25-hydroxycholecalciferol and as source of binding protein, rat renal cytosol. The characteristics of the binding protein and the presence in human plasma of significant quantities of 24,25-dihydroxyvitamin D render necessary the chromatographic stage. This technic permits one to measure simply and specifically 25-hydroxyvitamin D in the human serum, of which normal levels (average +/- standard deviation) are 12.88 +/- 5.42 microgram/l 3.2.10(-8) + 1.35.10(-8) mol/l).
本文描述了一种对人血清中25-羟基维生素D进行放射竞争性估计的方法。提取后,通过在葡聚糖LH 20柱上进行色谱纯化阶段,可将25-羟基维生素D与维生素D及其他代谢产物分离。放射竞争反应使用氚标记的25-羟基胆钙化醇作为示踪剂,并使用大鼠肾细胞溶质作为结合蛋白的来源。结合蛋白的特性以及人血浆中大量24,25-二羟基维生素D的存在使得色谱阶段成为必要。该技术允许简单且特异性地测量人血清中的25-羟基维生素D,其正常水平(平均值±标准差)为12.88±5.42微克/升(3.2×10⁻⁸ + 1.35×10⁻⁸摩尔/升)。